alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
KIRKLIN THOMPSON &POPE LLP 

1000 SW Broadway, Suite 1616, Portland, OR 97205-3035 

(TEL) 503-222-1640 (FAX) 503-227-5251 www.ktp-law.com 

Kristen Chambers OSB 130882 

Kirklin Thompson & Pope LLP 

1000 SW Broadway, Suite 1616 

Portland, OR 97205-3035 

(503) 222-1640 

kristen@ktp-law.com

 

Attorneys for Plaintiffs Loren and Valerie Kruesi 

 UNITED STATES DISTRICT COURT 

DISTRICT OF OREGON 

Loren and Valerie Kruesi, 

individuals, 

Plaintiffs, 

v. 

Linn County, 

a municipal corporation; and 

Bruce Davis; David Snippen; and Rick 

Campbell, 

individuals in their individual capacities, 

Defendants. 

Case No. 6:14-cv-01465-TC 

Stipulation to Filing of Plaintiffs’ Fifth 

Amended Complaint

 

Pursuant to Fed. R. Civ. Pro. 15(a)(2), Defendants consent to the filing of Plaintiffs’ 

Fifth Amended Complaint. 

Dated April 10, 2015. 

 Respectfully submitted, 

KIRKLIN THOMPSON &POPELLP

 

_____________________________________ 

Kristen Chambers OSB 130882 

Attorneys for Plaintiffs 

Loren and Valerie Kruesi 
Stipulation to Filing of Plaintiffs’ Fifth Amended Complaint

Page 1 

KIRKLIN THOMPSON &POPE LLP 

1000 SW Broadway, Suite 1616, Portland, OR 97205-3035 

(TEL) 503-222-1640 (FAX) 503-227-5251 www.ktp-law.com 

/s/ Gerald Warren 

Gerald Warren OSB 814146 

Attorney for Defendants Linn County, 

Bruce Davis, David Snippen, and Rick 

Campbell
Certificate of Service

 

KIRKLIN THOMPSON &POPE LLP 

1000 SW Broadway, Suite 1616, Portland, OR 97205-3035 

(TEL) 503-222-1640 (FAX) 503-227-5251 www.ktp-law.com 

Certificate of Service 

 I certify that on April 10, 2015, I caused to be served a copy of the foregoing 

Stipulation to Filing of Plaintiffs’ Fifth Amended Complaint by CM/ECF and mail on 

the following person: 

Gerald L. Warren 

Law Office of Gerald Warren 

901 Capitol St. NE 

Salem, OR 97301 

gwarren@geraldwarrenlaw.com 

 Attorney for Defendants Linn 

County, Bruce Davis, David 

Snippen, and Rick Campbell 

 

 ______________________________________________ 

 Kristen Chambers
`[Congressional Bills 105th Congress]
[From the U.S. Government Publishing Office]
[S. 1700 Reported in Senate (RS)]






                                                       Calendar No. 486
105th CONGRESS
  2d Session
                                S. 1700

To designate the headquarters building of the Department of Housing and 
Urban Development in Washington, District of Columbia, as the ``Robert 
                     C. Weaver Federal Building''.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             March 3, 1998

   Mr. Moynihan (for himself, Mr. Kerry,  Ms. Moseley-Braun, and Mr. 
   Kennedy) introduced the following bill; which was read twice and 
       referred to the Committee on Environment and Public Works

                             July 22, 1998

               Reported by Mr. Chafee, without amendment

_______________________________________________________________________

                                 A BILL


 
To designate the headquarters building of the Department of Housing and 
Urban Development in Washington, District of Columbia, as the ``Robert 
                     C. Weaver Federal Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DESIGNATION OF ROBERT C. WEAVER FEDERAL BUILDING.

    In honor of the first Secretary of Housing and Urban Development, 
the headquarters building of the Department of Housing and Urban 
Development located at 451 Seventh Street, SW., in Washington, District 
of Columbia, shall be known and designated as the ``Robert C. Weaver 
Federal Building''.

SEC. 2. REFERENCES.

    Any reference in a law, map, regulation, document, paper, or other 
record of the United States to the building referred to in section 1 
shall be deemed to be a reference to the ``Robert C. Weaver Federal 
Building''.
                                     





                                                       Calendar No. 486

105th CONGRESS

  2d Session

                                S. 1700

_______________________________________________________________________

                                 A BILL

To designate the headquarters building of the Department of Housing and 
Urban Development in Washington, District of Columbia, as the ``Robert 
                     C. Weaver Federal Building''.

_______________________________________________________________________

                             July 22, 1998

                       Reported without amendment`
Appeal Dismissed and Memorandum Opinion filed June 23 , 2022

.

In The 

## Fourteenth Court of Appeals

NO. 14

- 22

- 00268

- CR

PHILLIP JAMES MOORE , Appellant

V.
THE STATE OF TEXAS , Appellee

On Appeal from the 209th District Court

Harris County, Texas Trial Cou rt Cause No. 1360768A

MEMORANDUM OPINION
Appellant filed a pro se notice of appeal complaining of the trial court ’ s findings of fact and conclusions of law, signed March 23, 2022.

Ge ner ally, an appellate court only has jurisdiction to consider an appeal b y a criminal defendant where there has been a final judgment of conviction. Workman
v. State , 170 Tex. Crim. 621, 343 S.W.2d 446, 447 (1961); McKown v. State , 915 S.W.2d 160, 161 (Te x. App.

-- Fort Worth 1996, no pet.). Th e record before this
contains no f

inal judgment of con viction or other appe alable order. Because this2

appeal does not fall within the exceptions to the general rule that appeal may be taken only from a final judgment of convic tion, we have no jurisdiction.
On May 1 6, 2022, this court no ti fied the parties that the appeal would be dismissed for lack of jurisdiction unless a party demonstrated that the court has jurisdiction within 21 days. No response has been filed.

W e d ismiss the appeal.

PER CURIAM

Panel consists of Chie f Justice Ch ri stopher and Justices Wise and Jewell.

Do Not Publish

— Tex. R. App. P. 47.2(b)
EXHIBIT 99.2


		THE PRUDENTIAL HOME MORTGAGE COMPANY, INC.
	OFFICER'S ANNUAL COMPLIANCE CERTIFICATE - SERIES 1995-1


The undersigned Vice Presidents of The Prudential Home Mortgage
Company, Inc., the servicer (the "Servicer") under the Pooling and
Servicing Agreement for the Series 1995-1 Mortgage Pass-Through
Certificates (the "Agreement") entered into by and among The
Prudential Home Mortgage Securities Company, Inc., the Servicer,
and First Trust National Association, the trustee (the "Trustee"),
hereby certify to the Trustee that:


		(i) a review of the activities of the
		Servicer during the preceding calendar
		year and of its performance under the
		Agreement has been made under the
		undersigned's supervision, and

		(ii) to the best of the undersigned's
		knowledge, based on such review, the
		Servicer has fulfilled all its obligations
		under the Agreement throughout such year.


Capitalized terms not defined herein shall have the meaning given
to them in the Agreement.


Date:  March 11, 1996


By:     /s/ELAINE STANGL
Name:   Elaine Stangl
Title:  Vice President


By:     /s/KEN PETERS
Name:   Ken Peters
Title:  Vice President
Exhibit
32.2




CERTIFICATION




The
undersigned hereby certifies, in accordance with 18 U.S.C. 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an
officer of Inter Parfums, Inc., that the Annual Report of Inter Parfums, Inc. on
Form 10-K for the year ended  December 31, 2009, fully complies with
the requirements of Section 13(a) of the Securities Exchange Act of 1934 and
that the information contained in such report fairly presents, in all material
respects, the financial condition and results of operation of Inter Parfums,
Inc.




Date:
      March 10, 2010
                By:
                /s/ Russell GreenbergRussell
      GreenbergExecutive
      Vice President,Chief
      Financial Officer andPrincipal
      Accounting Officer




A signed
original of this written statement required by Section 906 has been provided to
Inter Parfums, Inc. and will be retained by Inter Parfums, Inc. and furnished to
the Securities and Exchange Commission or its staff upon request.
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Foreign Disease-Weed Science Research: Frederick, MD
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    CareersSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Northeast Area Frederick, Maryland Foreign Disease-Weed Science Research People & Locations







Dustin  Hancock
                        Foreign Disease-Weed Science Research

                        




                        
                        BIOLOGICAL SCIENCE TECHNICIAN
                        Phone: (301) 619-2878
                        
                        
                        Fax: (Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
EXHIBIT 99.2


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In  connection  with  the annual report of eLinear, Inc. (the "Company") on Form
10-KSB/A  for  the year ended December 31, 2002 as filed with the Securities and
Exchange  Commission  on  the  date  hereof  (the  "Report"),  I, Kevan M Casey,
President  and Principal Accounting Officer of the Company, certify, pursuant to
18 U.S.C. section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act  of  2002,  that  to  the  best  of  my  knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of
the  Securities  Exchange  Act  of  1934;  and

(2)  The  information  contained  in the Report fairly presents, in all material
respects,  the  financial  condition  and  results of operations of the Company.



/s/  Kevan M. Casey
---------------------------------
Kevan M. Casey, President and Principal
Accounting Officer
April 30, 2003


     A  signed  original  of  this written statement required by Section 906 has
been  provided  to  eLinear,  Inc.  and  will  be  retained by eLinear, Inc. and
furnished  to  the Securities and Exchange Commission or its staff upon request.


<PAGE>
Exhibit 32-2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Financial Report of NoFire Technologies, Inc. on Form
10KSB/A  for the Fiscal Year ended 8/31/2004  as filed with the Securities and
Exchange Commission on the date hereof, I, Sam Oolie, Chief Financial Officer
Of  the  Company, certify, pursuant to 18 U.S.C 1350, as adopted pursuant to
906 of  the Sarbanes-Oxley Act of 2002, that:

(1) The Form 10QKB/A  fully complies with the requirements of Section 13 (a)
or 15 (d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2) The information contained in the Form 10KSB/A  fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Dated April  27, 2005





Name    Sam Oolie (CFO)


A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature
that appears in typed form within the electronic version of this written
statement required by Section 906, has been provided to NoFire Technologies,
Inc. and will be retained by NoFire Technologies, Inc. and furnished to the
Securities and Exchange Commission or its staff upon request.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FINANCIAL
STATEMENTS FOR THE PERIOD FROM APRIL 1, 1999 TO MARCH 31, 2000 AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          MAR-31-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                         449,429
<SECURITIES>                                         0
<RECEIVABLES>                                3,879,893
<ALLOWANCES>                                  (50,000)
<INVENTORY>                                  1,007,464
<CURRENT-ASSETS>                             6,718,748
<PP&E>                                       9,496,844
<DEPRECIATION>                             (4,386,147)
<TOTAL-ASSETS>                              13,031,191
<CURRENT-LIABILITIES>                        6,689,396
<BONDS>                                      1,881,900
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                  3,085,728
<COMMON>                                     5,933,226
<OTHER-SE>                                 (4,699,398)
<TOTAL-LIABILITY-AND-EQUITY>                13,031,191
<SALES>                                              0
<TOTAL-REVENUES>                            23,593,187
<CGS>                                                0
<TOTAL-COSTS>                               20,272,303
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             347,337
<INCOME-PRETAX>                                379,021
<INCOME-TAX>                                 (139,000)
<INCOME-CONTINUING>                            518,022
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   518,022
<EPS-BASIC>                                       0.02
<EPS-DILUTED>                                     0.02


</TABLE>
**EXHIBIT 23.1**
**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**
     We consent to the incorporation by reference in Registration Statement Nos. 33-35941, 33-43868,33-43866, 33-45994, 33-45142, 33-54382, 33-65125, 33-69946, 33-75088, 333-28593 and 333-80729 onForm S-3 and the Registration Statement Nos. 33-85154, 333-72916, 333-72918, 333-72920, 333-113387,333-113388, 333-126651 and 333-134432 on Form S-8 of our reports dated March 17, 2008,relating to the consolidated financial statements of Bentley Pharmaceuticals, Inc. andsubsidiaries (which report expresses an unqualified opinion and includes an explanatory paragraphrelating to the adoption of Financial Accounting Standards Board (“FASB”) Interpretation No.48, *Accounting for Uncertainty in Income Taxes — an interpretation of FASB Statement No. 109*,effective January 1, 2007, and Statement of Financial Accounting Standards No. 123(Revised),*Share-Based Payment,*effective January 1, 2006) and the effectiveness of Bentley Pharmaceuticals,Inc. and subsidiaries’ internal control over financial reporting (whichreport expresses an adverse opinion because of a material weakness), appearing in this AnnualReport on Form 10-K of Bentley Pharmaceuticals, Inc. and subsidiaries for the year ended December31, 2007.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
```

[Congressional Bills 105th Congress]
[From the U.S. Government Publishing Office]
[S. 1661 Introduced in Senate (IS)]

105th CONGRESS
  2d Session
                                S. 1661

 To suspend temporarily the duty on N-Ethylmorpholine, cmpd. with 3-(4-
                  methylbenzoyl) propanoic acid (1:2).

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           February 12, 1998

 Mr. Moynihan introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
 To suspend temporarily the duty on N-Ethylmorpholine, cmpd. with 3-(4-
                  methylbenzoyl) propanoic acid (1:2).

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SUSPENSION OF DUTY.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new item:
    

         ``    9902.32.32     N-                                                                                
                               Ethylmorpholine,                                                                 
                               cmpd. with 3-(4-                                                                 
                               methylbenzoyl)                                                                   
                               propanoic acid                                                                   
                               (1:2) (CAS No.                                                                   
                               171054-89-0)                                                                     
                               (provided for in                                                                 
                               subheading                                                                       
                               2934.90.39).....  Free        No change        No change       On or before      
                                                                                               12/31/2000       
                                                                                                              ''

    (b) Applicability.--The amendment made by this section applies with 
respect to goods entered, or withdrawn from warehouse for consumption, 
on or after the 15th day after the date of enactment of this Act.
                                 <all>
```
#### UNITED STATES of America, Plaintiff-Appellee v. Antonio Silva SEGURA, also known as Antonio Segura-Ramirez, Defendant-Appellant.

No. 10-40311

Summary Calendar.

United States Court of Appeals, Fifth Circuit.

March 28, 2011.

James Lee Turner, Assistant U.S. Attorney, U.S. Attorney’s Office, Houston, TX, for Plaintiff-Appellee.

*718Marjorie A. Meyers, Federal Public Defender, Timothy William Crooks, Assistant Federal Public Defender, Molly Estelle Odom, Esq., Assistant Federal Public Defender, Federal Public Defender’s Office, Houston, TX, for Defendant-Appellant.

Before JONES, Chief Judge, and JOLLY and SOUTHWICK, Circuit Judges.

PER CURIAM: *

Antonio Silva Segura (Silva) appeals his sentence for illegal reentry in violation of 8 U.S.C. § 1326(a) and (b)(1). The guidelines range of imprisonment was 24 to 30 months. Silva was sentenced to 60 months of imprisonment and three years of supervised release.

Silva contends that the district court abused its discretion by denying his implied request for a continuance. This claim of error is unfounded as Silva made only an implied request after sentence was pronounced. Assuming arguendo that this claim of error is subject to the abuse of discretion standard, see *United States v. Barnett,*197 F.3d 138, 144 (5th Cir.1999), Silva lacks a legitimate basis for claiming that the factual basis of the sentence was a surprise or that the surprise was prejudicial, *see Irizarry v. United States,*553 U.S. 708, 715-16, 128 S.Ct. 2198, 171 L.Ed.2d 28 (2008). Therefore, he has not demonstrated any error, plain or otherwise.

Silva also contends that the district court failed to adequately explain the extent of the variance and that the sentence was substantively unreasonable. Sentences are reviewed under an abuse of discretion standard for procedural error and substantive reasonableness. *Gall v. United States,*552 U.S. 38, 51, 128 S.Ct. 586, 169 L.Ed.2d 445 (2007). Because Silva did not object to the adequacy of the district court’s reasons for imposing sentence, review is for plain error. *See United States v. Mondragon-Santiago,*564 F.3d 357, 361 (5th Cir.), *cert. denied,*— U.S.-, 130 S.Ct. 192, 175 L.Ed.2d 120 (2009). It is apparent from the record how and why the district selected the 60-month sentence, and Silva has failed to show that the district court committed any procedural error, plain or otherwise. *See United States v. Lopez-Velasquez,*526 F.3d 804, 806-07 (5th Cir.2008).

Silva’s objection to the sentence as being greater than necessary under the 18 U.S.C. § 3553(a) factors preserved his claim of error with respect to the substantive reasonableness of the sentence. *See Mondragortr-Santiago,*564 F.3d at 361. The 60-month sentence was substantively reasonable as the district court justified the 30-month variance based on a proper application and weighing of the § 3553(a) factors. *See United States v. Smith,*440 F.3d 704, 708-10 (5th Cir.2006).

The judgment of the district court is AFFIRMED.

*

 Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.